Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Jan 07 2022

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jan-07-2022-10

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 07, 2022, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Vortioxetine Tablets 5 mg, 10 mg, 15 mg, and 20 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases